Lynne Atley

1.2k total citations
17 papers, 941 citations indexed

About

Lynne Atley is a scholar working on Endocrinology, Diabetes and Metabolism, Rheumatology and Molecular Biology. According to data from OpenAlex, Lynne Atley has authored 17 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Rheumatology and 5 papers in Molecular Biology. Recurrent topics in Lynne Atley's work include Osteoarthritis Treatment and Mechanisms (5 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Knee injuries and reconstruction techniques (4 papers). Lynne Atley is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (5 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Knee injuries and reconstruction techniques (4 papers). Lynne Atley collaborates with scholars based in Australia, United States and Canada. Lynne Atley's co-authors include David R. Eyre, Terri Pietka, Stefan Lohmander, John D. Wark, Peter R. Ebeling, Henry Burger, J. R. Guthrie, L Dennerstein, John L. Hopper and John R. Matyas and has published in prestigious journals such as American Journal of Clinical Nutrition, The Journal of Clinical Endocrinology & Metabolism and Journal of Bone and Mineral Research.

In The Last Decade

Lynne Atley

17 papers receiving 912 citations

Peers

Countries citing papers authored by Lynne Atley

Since Specialization

Citations

This map shows the geographic impact of Lynne Atley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynne Atley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynne Atley more than expected).

Fields of papers citing papers by Lynne Atley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynne Atley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynne Atley. The network helps show where Lynne Atley may publish in the future.

Co-authorship network of co-authors of Lynne Atley

This figure shows the co-authorship network connecting the top 25 collaborators of Lynne Atley. A scholar is included among the top collaborators of Lynne Atley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynne Atley. Lynne Atley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly 2018 ·European Journal of Endocrinology ·Peter Trainer, John Newell‐Price, John Ayuk, Simon Aylwin, Aled Rees, William Drake, Philippe Chanson, Thierry Brue, Susan M. Webb, Carmen Fajardo, Javier Aller, Ann McCormack, David J. Torpy, George Tachas, Lynne Atley, David Ryder, Martin Bidlingmaier	29
2	A phase 2 study of antisense oligonucleotide therapy directed at the GH receptor demonstrates lowering of serum IGF1 in patients with acromegaly. 2015 ·Endocrine Abstracts ·Peter Trainer, John Newell‐Price, John Ayuk, Simon Aylwin, Aled Rees, Will Drake, Philippe Chanson, Thierry Brue, Susan M. Webb, Carmen Fajardo, Javier Aller, Ann McCormack, David J. Torpy, George Tachas, Lynne Atley, Martin Bidlingmaier	3
3	Antisense oligonucleotide targeting of insulin‐like growth factor‐1 receptor (IGF‐1R) in prostate cancer 2009 ·The Prostate ·Junya Furukawa, Christopher J. Wraight, Susan M. Freier, (unknown), Lynne Atley, Brett P. Monia, Martin Gleave, Michael Cox	32
4	Sport-related differences in biomarkers of bone resorption and cartilage degradation in endurance athletes 2005 ·Osteoarthritis and Cartilage ·John W. O’Kane, Eric K. Hutchinson, Lynne Atley, David R. Eyre	47
5	Increase in degraded collagen type II in synovial fluid early in the rabbit meniscectomy model of osteoarthritis 2004 ·Osteoarthritis and Cartilage ·E. Lindhorst, Lydia Wachsmuth, (unknown), R. Raiss, Thomas Aigner, Lynne Atley, David R. Eyre	36
6	Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis 2004 ·Arthritis & Rheumatism ·John R. Matyas, Lynne Atley, Mirela Ionescu, David R. Eyre, A. Robin Poole	132
7	The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis 2003 ·Arthritis & Rheumatism ·Stefan Lohmander, Lynne Atley, Terri Pietka, David R. Eyre	197
8	Neoepitopes as biomarkers of cartilage catabolism 2003 ·Inflammation Research ·Amanda Fosang, Heather Stanton, Christopher B. Little, Lynne Atley	32
9	Sequence Dependence of C5-Propynyl-dU,dC-Phosphorothioate Oligonucleotide Inhibition of the Human IGF-I Receptor: mRNA, Protein, and Cell Growth 2002 ·Antisense and Nucleic Acid Drug Development ·Rhys D. Fogarty, (unknown), Paul J. White, Lynne Atley, George A. Werther, Christopher J. Wraight	5
10	Proteolysis of human bone collagen by cathepsin K: characterization of the cleavage sites generating the cross-linked N-telopeptide neoepitope 2000 ·Bone ·Lynne Atley, John S. Mort, Manon Lalumière, David R. Eyre	73
11	Premenopausal Ovariectomy-Related Bone Loss: A Randomized, Double-Blind, One-Year Trial of Conjugated Estrogen or Medroxyprogesterone Acetate 1997 ·Journal of Bone and Mineral Research ·Jerilynn C. Prior, Yvette M. Vigna, John D. Wark, David W. Eyre, Brian C. Lentle, David K.B. Li, Peter R. Ebeling, Lynne Atley	89
12	Bone Turnover Markers and Bone Density Across the Menopausal Transition 1997 ·Obstetrical & Gynecological Survey ·Peter R. Ebeling, Lynne Atley, Janet R. Guthrie, Henry Burger, Lorraine Dennerstein, John L. Hopper, John D. Wark	3
13	Bone turnover markers and bone density across the menopausal transition. 1996 ·The Journal of Clinical Endocrinology & Metabolism ·Peter R. Ebeling, Lynne Atley, J. R. Guthrie, Henry Burger, L Dennerstein, John L. Hopper, John D. Wark	235
14	1,25-Dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells 1995 ·Journal of Endocrinology ·Lynne Atley, (unknown), John D. Wark	6
15	Temporal study of metabolic change when poorly controlled noninsulin-dependent diabetics change from low to high carbohydrate and fiber diet 1988 ·American Journal of Clinical Nutrition ·(unknown), (unknown), Wahlqvist Ml, (unknown), Mark Sissons, Lynne Atley	9
16	A Rapid, Sensitive and Reliable Assay for Inhibin Bioactivity 1987 ·Australian Journal of Biological Sciences ·(unknown), (unknown), Helen Quigg, Lynne Atley, (unknown), Lorraine Leversha, Henry Burger	9
17	Chromosomal Variants and Male Fertility 1981 ·Fertility and Sterility ·(unknown), Lynne Atley, (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact